Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
The downside that can come from buying these securities is precisely why we started StockStory - to isolate the long-term winners from the losers so you can invest with confidence. Keeping that in mind, here is one small-cap stock that could amplify your portfolio's returns and two that could be down big.
Two Small-Cap Stocks to Sell:
Chemed (CHE)
Market Cap: $7.15 billion
With a unique business model combining end-of-life care and household services, Chemed (NYSE:CHE) operates two distinct businesses: VITAS, which provides hospice care for terminally ill patients, and Roto-Rooter, which offers plumbing and water restoration services.
Why Does CHE Give Us Pause?
Chemed's stock price of $548.92 implies a valuation ratio of 21.1x forward P/E. Check out our free in-depth research report to learn more about why CHE doesn't pass our bar.
Home Bancshares (HOMB)
Market Cap: $6.18 billion
Founded in...
Source: https://ca.finance.yahoo.com/news/1-small-cap-stock-target-105322766.html
- Log in to post comments
Link